Product Information
ALFUZOSIN HCL ER 10 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1074 per EA under NDC 47335095688. Its NADAC has been published 639 times since Nov 28, 2013.
FDA first approved this application on Jul 18, 2011.
Strength
10 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335095688
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
ALFUZOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079057FDA Approved
7/18/2011
On Market Since
11/22/2011
Pharmacological Classes
Price Statistics
The NADAC for ALFUZOSIN HCL ER 10 MG TABLET has been published 639 times since Nov 28, 2013, and over the history we have for it it has declined 55.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1074 per EA |
|---|---|
| All-time high | $0.2665 (Mar 11, 2015) |
| All-time low | $0.1034 (Jan 22, 2025) |
| 52-week high | $0.1078 |
| 52-week low | $0.1052 |
| Median price | $0.1371 |
| Average price | $0.1576 |
| Largest weekly change | +32.0% (Nov 22, 2023) |
| Weeks tracked | 639 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+2.0%
3Y
-5.2%
5Y
-24.1%
All
-55.0%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Alfuzosin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALFUZOSIN HCL ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALFUZOSIN HCL ER 10 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.1074 per EA (NDC 47335095688), effective Feb 18, 2026.
How has the price of ALFUZOSIN HCL ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has declined 55.0%. It has been tracked across 639 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALFUZOSIN HCL ER 10 MG TABLET?
Since Nov 28, 2013, the NADAC for ALFUZOSIN HCL ER 10 MG TABLET has ranged from a low of $0.1034 (Jan 22, 2025) to a high of $0.2665 (Mar 11, 2015), with a median of $0.1371 per EA.
Are there cheaper alternatives to ALFUZOSIN HCL ER 10 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALFUZOSIN HCL ER 10 MG TABLET, is $0.1051 per EA — about 2% below ALFUZOSIN HCL ER 10 MG TABLET.
Who manufactures ALFUZOSIN HCL ER 10 MG TABLET?
ALFUZOSIN HCL ER 10 MG TABLET (NDC 47335095688) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.